EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 21st, 2018 • GT Biopharma, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 21st, 2018 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into by and among GT Biopharma, Inc. (the Company) and Shawn Cross ("Executive") as of February 15, 2018 (the "Effective Date").
CONSULTANT AGREEMENTConsultant Agreement • February 21st, 2018 • GT Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 21st, 2018 Company Industry JurisdictionThis CONSULTANT AGREEMENT (the “Agreement”) is made and entered into as of February 14, 2018, by and among GT Biopharma, Inc. (the “Parent”), Georgetown Translational Pharmaceuticals, Inc. (the “Subsidiary,” and collectively, the “Companies”), and Anthony J. Cataldo (the “Consultant,” and together with the Companies, the “Parties”).
FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENTEmployment Agreement • February 21st, 2018 • GT Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 21st, 2018 Company IndustryThis FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into as of February 14, 2018, by and among GT Biopharma, Inc. (the “Parent”), Georgetown Translational Pharmaceuticals, Inc. (the “Subsidiary,” and collectively, the “Companies”), and Kathleen Clarence-Smith (the “Executive,” and together with the Companies, the “Parties”).